Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

G&E Herbal Biotechnology Co., Ltd. (4911) Financial Statements

G&E Herbal Biotechnology Co., Ltd. Financial Overview

G&E Herbal Biotechnology Co., Ltd.'s market cap is currently NT$1.74B. The company's EPS TTM is NT$1.34; its P/E ratio is 18.66; and it has a dividend yield of 4.66%. G&E Herbal Biotechnology Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 309.13MNT$ 249.03MNT$ 181.44MNT$ 64.61MNT$ 24.57M
Gross ProfitNT$ 259.60MNT$ 205.34MNT$ 144.59MNT$ 39.35MNT$ 9.63M
Operating IncomeNT$ 152.30MNT$ 119.65MNT$ 80.68MNT$ 7.23MNT$ -19.56M
EBITDANT$ 162.91MNT$ 135.15MNT$ 99.84MNT$ 16.63MNT$ -10.22M
Net IncomeNT$ 139.20MNT$ 102.06MNT$ 72.40MNT$ 7.38MNT$ -19.88M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 430.31MNT$ 408.87MNT$ 312.92MNT$ 205.95MNT$ 108.88M
Total AssetsNT$ 975.22MNT$ 959.17MNT$ 883.10MNT$ 782.77MNT$ 692.13M
Total DebtNT$ 6.96MNT$ 8.09MNT$ 5.43MNT$ 6.39MNT$ 2.62M
Net DebtNT$ -71.46MNT$ -144.49MNT$ -134.25MNT$ -108.36MNT$ -9.66M
Total LiabilitiesNT$ 47.15MNT$ 125.64MNT$ 119.86MNT$ 91.94MNT$ 8.68M
Stockholders' EquityNT$ 928.07MNT$ 833.53MNT$ 763.24MNT$ 690.84MNT$ 683.45M
Cash Flow
Free Cash FlowNT$ 66.97MNT$ 128.68MNT$ 107.96MNT$ 97.00MNT$ -11.18M
Operating Cash FlowNT$ 70.18MNT$ 134.68MNT$ 113.48MNT$ 99.96MNT$ -9.19M
Investing Cash FlowNT$ -98.81MNT$ -89.24MNT$ -88.43MNT$ 2.50MNT$ 7.01M
Financing Cash FlowNT$ -45.53MNT$ -32.54MNT$ -116.00KNT$ 0.00NT$ 0.00

Currency in TWD

G&E Herbal Biotechnology Co., Ltd. Earnings and Revenue History

-200M0200M400M-160 %-80 %0 %80 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

G&E Herbal Biotechnology Co., Ltd. Liabilities to Assets

0400M800M1.2B0 %5 %10 %15 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

G&E Herbal Biotechnology Co., Ltd. Cash Flow

-150M-100M-50M050M100M150M2019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

G&E Herbal Biotechnology Co., Ltd. Forecast EPS vs Actual EPS

00.10.20.30.40.50.6Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26EPS EstimateBeatMiss
Earnings >